Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

According to Bloomberg, Activist investor Elliott pushes Healthcare Trust of America (HTA) to sell itself

  • October 7, 2021


StockHealthcare Trust of America, Inc.SymbolHTA
Date Announced10/06/2021Source Bloomberg
TypeNews Report
Date of Confirmation: 02/28/2022Price at Confirmation: $29.39
Potential Profit: -5.41%Annualized Profit: -13.61%

Activist investor Elliott Investment Management has built a position in Healthcare Trust of America Inc. (HTA) and is pushing for the real estate investment trust to launch a strategic review that includes a potential sale of the company, according to people familiar with the matter.


November 05, 2021: Healthcare Trust of America Inc. (HTA) Board has been actively engaged in a strategic review process and, with the support of its financial advisor, J.P. Morgan Securities LLC, is evaluating a wide range of options, including, among others, a corporate sale or merger, joint ventures and partnerships, asset sales, and continued operation as an independent public company.

November 05, 2021: Elliott supports the Healthcare Trust of America Inc. (HTA) announcement to run a strategic review, including the evaluation of a sale of the Company.

February 24, 2022: Healthcare Trust of America Inc., (HTA) which owns and operates medical-office buildings around the country, is in advanced talks to combine with smaller rival Healthcare Realty Trust Inc. (HR) in a deal that could create a company worth more than $10 billion.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.